Product nameAnti-D4 GDI antibody
See all D4 GDI primary antibodies
DescriptionRabbit polyclonal to D4 GDI
Tested applicationsSuitable for: IHC-P, WBmore details
Species reactivityReacts with: Human
Recombinant full length protein corresponding to Human D4 GDI.
Database link: P52566
- Placenta and tonsil.
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferpH: 7.6
Preservative: 0.1% Sodium azide
Constituents: PBS, 1% BSA
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab15198 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
1/100 for 10 min at RT. Boil tissue sections in 10mM citrate buffer, pH 6.0 for 10 min followed by cooling at RT for 20 min.
|WB||Use a concentration of 1 µg/ml. Predicted molecular weight: 23 kDa.|
FunctionRegulates the GDP/GTP exchange reaction of the Rho proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them (PubMed:8356058, PubMed:7512369). Regulates reorganization of the actin cytoskeleton mediated by Rho family members (PubMed:8262133).
Tissue specificityDetected in bone marrow, thymus and spleen.
Sequence similaritiesBelongs to the Rho GDI family.
Cellular localizationCytoplasm, cytosol.
- Information by UniProt
- Arhgdib antibody
- D4 antibody
- D4 GDP dissociation inhibitor antibody
This product has been referenced in:
- Mercey O et al. Characterizing isomiR variants within the microRNA-34/449 family. FEBS Lett 591:693-705 (2017). WB . Read more (PubMed: 28192603) »
- Lai MC et al. Prognostic value of Rho GDP dissociation inhibitors in patients with hepatocellular carcinoma following liver transplantation. Oncol Lett 14:1395-1402 (2017). Read more (PubMed: 28789355) »